Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas
1997

Gut Peptide Receptors in Human Pancreatic Cancer

Sample size: 22 publication Evidence: moderate

Author Information

Author(s): C Tang, I Biemond, GJA Offerhaus, W Verspaget, CBHW Lamers

Primary Institution: University Hospital Leiden, The Netherlands; Academic Medical Center, Amsterdam, The Netherlands

Hypothesis

The expression of gut peptide receptors in pancreatic cancer differs from that in tumour-free pancreas.

Conclusion

The study found that receptors for gut peptides are present in only a minority of pancreatic cancer specimens.

Supporting Evidence

  • CCK-B receptors were not detected in any of the pancreatic cancers.
  • BBS receptors were absent in 10 of 12 pancreatic cancers.
  • Secretin receptors were visualized in 5 of 12 pancreatic cancers.
  • VIP receptors were identified in 3 of 12 pancreatic cancer specimens.

Takeaway

This study looked at how certain receptors in the pancreas work differently in cancer compared to healthy tissue.

Methodology

The study used storage phosphor autoradiography to visualize and compare gut peptide receptors in tissue sections from healthy and cancerous pancreas.

Limitations

The study only included a small number of pancreatic cancer specimens and did not explore all potential receptor types.

Participant Demographics

10 control patients (6 men, 4 women) with an average age of 50 years; 12 pancreatic cancer patients (7 men, 5 women) with an average age of 66 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication